"Giving it a shot", 1st Nov 2014

The pharmaceutical industry has long neglected vaccines, not least because they are mostly needed by countries too poor to pay much for them. However, as concern about the current Ebola outbreak has grown, work on several candidates has been stepped up. This has involved unprecedented collaboration between companies, regulators, governments and bodies such as the WHO. Two candidates, GSK’s [GlaxoSmithKline] and one from NewLink Genetics…will be ready for testing in West Africa by the end of the year…Staff at GSK and J&J [Johnson & Johnson] say they are working around the clock to accelerate production and that efforts are being driven by humanitarian need rather than any assumption that they will be profitable...[Also refers to Bavarian Nordic, Okairos, Pfizer, Profectus BioSciences]